Webinars, Pharmaceutical

Aptar Pharma Hosts Webinar on Raising the Bar for Injectable Drugs

Aptar Pharma will host a live educational webinar entitled “Raising the Bar for Injectable Drugs: EU GMP Annex 1 and its Impact”.

Join this webinar on:

March 5, 2024
9:00 AM London / 4:00 PM Beijing


March 5, 2024 3:30 PM London / 10:30 AM New York
Register for 9am London Session Register for 3:30pm London Session
Presented by Estelle Verger Wendy Durand
3 Jan 2024

The pharmaceutical industry is on the brink of a significant transformation with the European Medicine Agency’s recent revision of Annex 1 of Good Manufacturing Practices (GMP). To address this pivotal change, Aptar Pharma, a global leader in drug delivery systems, components, and services, is pleased to announce an educational webinar on the recent revisions of Annex 1 of Good Manufacturing Practices entitled “Raising the Bar for Injectable Drugs: EU GMP Annex 1 and its Impact”, emphasizing the new guidelines for patient safety and contamination control.

Particulate and microbial contamination are leading causes of FDA recalls and pose severe risks to patient health. The revised EU GMP Annex 1 places stringent quality standards on pharmaceutical manufacturers, thereby increasing the responsibility to safeguard against these risks.

This webinar aims to demystify the complexities of the Annex 1 revision and its implications on the pharmaceutical industry. Experts will explore how these new guidelines will impact industrial strategies, including the roles of sterile primary packaging suppliers and closure components manufacturers in ensuring compliance with the EMA GMP Annex 1. The key topics covered in the webinar include Establishing a Contamination Control Strategy, as well as offering insights into mitigating the risks of particulate and microbial contamination. The webinar will also review Aseptic Transfer Best Practices and the Guidelines on the aseptic transfer of components on filling lines. We will also discuss Guaranteeing Sterility of Primary Packaging Components to ensure the sterility of components at the time of use.

Aptar Pharma’s experts will also showcase how Aptar Pharma’s innovative solutions align with the new Annex 1 guidelines, offering tangible benefits to pharmaceutical manufacturers.

This webinar is a must-attend event for professionals in the pharmaceutical industry who are looking to stay ahead in contamination control and compliance with the latest EMA GMP Annex 1 revision guidelines.

Registration is now open, and attendance is free. To reserve your spot, please click on the links below.

Register for 9am London Session

Register for 3:30pm London Session

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 countries.
For more information, visit www.aptar.com/pharmaceutical


Back To Top